182 related articles for article (PubMed ID: 21366909)
1. Myelination in the absence of UDP-galactose:ceramide galactosyl-transferase and fatty acid 2 -hydroxylase.
Meixner M; Jungnickel J; Grothe C; Gieselmann V; Eckhardt M
BMC Neurosci; 2011 Mar; 12():22. PubMed ID: 21366909
[TBL] [Abstract][Full Text] [Related]
2. Oligodendrocyte-specific ceramide galactosyltransferase (CGT) expression phenotypically rescues CGT-deficient mice and demonstrates that CGT activity does not limit brain galactosylceramide level.
Zöller I; Büssow H; Gieselmann V; Eckhardt M
Glia; 2005 Nov; 52(3):190-8. PubMed ID: 15968630
[TBL] [Abstract][Full Text] [Related]
3. Absence of 2-hydroxylated sphingolipids is compatible with normal neural development but causes late-onset axon and myelin sheath degeneration.
Zöller I; Meixner M; Hartmann D; Büssow H; Meyer R; Gieselmann V; Eckhardt M
J Neurosci; 2008 Sep; 28(39):9741-54. PubMed ID: 18815260
[TBL] [Abstract][Full Text] [Related]
4. Reversal of non-hydroxy:alpha-hydroxy galactosylceramide ratio and unstable myelin in transgenic mice overexpressing UDP-galactose:ceramide galactosyltransferase.
Fewou SN; Büssow H; Schaeren-Wiemers N; Vanier MT; Macklin WB; Gieselmann V; Eckhardt M
J Neurochem; 2005 Jul; 94(2):469-81. PubMed ID: 15998297
[TBL] [Abstract][Full Text] [Related]
5. Kidney lipids in galactosylceramide synthase-deficient mice. Absence of galactosylsulfatide and compensatory increase in more polar sulfoglycolipids.
Tadano-Aritomi K; Hikita T; Fujimoto H; Suzuki K; Motegi K; Ishizuka I
J Lipid Res; 2000 Aug; 41(8):1237-43. PubMed ID: 10946011
[TBL] [Abstract][Full Text] [Related]
6. Absence of oligodendroglial glucosylceramide synthesis does not result in CNS myelin abnormalities or alter the dysmyelinating phenotype of CGT-deficient mice.
Saadat L; Dupree JL; Kilkus J; Han X; Traka M; Proia RL; Dawson G; Popko B
Glia; 2010 Mar; 58(4):391-8. PubMed ID: 19705459
[TBL] [Abstract][Full Text] [Related]
7. Myelination in the absence of galactocerebroside and sulfatide: normal structure with abnormal function and regional instability.
Coetzee T; Fujita N; Dupree J; Shi R; Blight A; Suzuki K; Suzuki K; Popko B
Cell; 1996 Jul; 86(2):209-19. PubMed ID: 8706126
[TBL] [Abstract][Full Text] [Related]
8. FA2H is responsible for the formation of 2-hydroxy galactolipids in peripheral nervous system myelin.
Maldonado EN; Alderson NL; Monje PV; Wood PM; Hama H
J Lipid Res; 2008 Jan; 49(1):153-61. PubMed ID: 17901466
[TBL] [Abstract][Full Text] [Related]
9. Ceramide galactosyltransferase expression is regulated positively by Nkx2.2 and negatively by OLIG2.
Okahara K; Kizuka Y; Kitazume S; Ota F; Nakajima K; Hirabayashi Y; Maekawa M; Yoshikawa T; Taniguchi N
Glycobiology; 2014 Oct; 24(10):926-34. PubMed ID: 24821492
[TBL] [Abstract][Full Text] [Related]
10. Divalent cation-mediated interaction between cerebroside sulfate and cerebrosides: an investigation of the effect of structural variations of lipids by electrospray ionization mass spectrometry.
Koshy KM; Wang J; Boggs JM
Biophys J; 1999 Jul; 77(1):306-18. PubMed ID: 10388759
[TBL] [Abstract][Full Text] [Related]
11. Composition and biophysical properties of myelin lipid define the neurological defects in galactocerebroside- and sulfatide-deficient mice.
Bosio A; Binczek E; Haupt WF; Stoffel W
J Neurochem; 1998 Jan; 70(1):308-15. PubMed ID: 9422376
[TBL] [Abstract][Full Text] [Related]
12. Sulfatide storage in neurons causes hyperexcitability and axonal degeneration in a mouse model of metachromatic leukodystrophy.
Eckhardt M; Hedayati KK; Pitsch J; Lüllmann-Rauch R; Beck H; Fewou SN; Gieselmann V
J Neurosci; 2007 Aug; 27(34):9009-21. PubMed ID: 17715338
[TBL] [Abstract][Full Text] [Related]
13. A mammalian fatty acid hydroxylase responsible for the formation of alpha-hydroxylated galactosylceramide in myelin.
Eckhardt M; Yaghootfam A; Fewou SN; Zöller I; Gieselmann V
Biochem J; 2005 May; 388(Pt 1):245-54. PubMed ID: 15658937
[TBL] [Abstract][Full Text] [Related]
14. Substrate reduction therapy for Krabbe disease and metachromatic leukodystrophy using a novel ceramide galactosyltransferase inhibitor.
Babcock MC; Mikulka CR; Wang B; Chandriani S; Chandra S; Xu Y; Webster K; Feng Y; Nelvagal HR; Giaramita A; Yip BK; Lo M; Jiang X; Chao Q; Woloszynek JC; Shen Y; Bhagwat S; Sands MS; Crawford BE
Sci Rep; 2021 Jul; 11(1):14486. PubMed ID: 34262084
[TBL] [Abstract][Full Text] [Related]
15. Myelin protein composition is altered in mice lacking either sulfated or both sulfated and non-sulfated galactolipids.
Fewou SN; Fernandes A; Stockdale K; Francone VP; Dupree JL; Rosenbluth J; Pfeiffer SE; Bansal R
J Neurochem; 2010 Feb; 112(3):599-610. PubMed ID: 19878436
[TBL] [Abstract][Full Text] [Related]
16. Central nervous system dysfunction in a mouse model of FA2H deficiency.
Potter KA; Kern MJ; Fullbright G; Bielawski J; Scherer SS; Yum SW; Li JJ; Cheng H; Han X; Venkata JK; Khan PA; Rohrer B; Hama H
Glia; 2011 Jul; 59(7):1009-21. PubMed ID: 21491498
[TBL] [Abstract][Full Text] [Related]
17. Genetic dissection of myelin galactolipid function.
Dupree JL; Popko B
J Neurocytol; 1999; 28(4-5):271-9. PubMed ID: 10739570
[TBL] [Abstract][Full Text] [Related]
18. Nur7 is a nonsense mutation in the mouse aspartoacylase gene that causes spongy degeneration of the CNS.
Traka M; Wollmann RL; Cerda SR; Dugas J; Barres BA; Popko B
J Neurosci; 2008 Nov; 28(45):11537-49. PubMed ID: 18987190
[TBL] [Abstract][Full Text] [Related]
19. Modest phenotypic improvements in ASA-deficient mice with only one UDP-galactose:ceramide-galactosyltransferase gene.
Franken S; Wittke D; Mansson JE; D'Hooge R; De Deyn PP; Lüllmann-Rauch R; Matzner U; Gieselmann V
Lipids Health Dis; 2006 Aug; 5():21. PubMed ID: 16893448
[TBL] [Abstract][Full Text] [Related]
20. Galactosphingolipids and axono-glial interaction in myelin of the central nervous system.
Bosio A; Büssow H; Adam J; Stoffel W
Cell Tissue Res; 1998 May; 292(2):199-210. PubMed ID: 9560463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
